Different Does of Acupuncture on Premenstrual Syndrome Efficacy Analysis

Sponsor
Taipei City Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04296422
Collaborator
(none)
105
1
3
20.6
5.1

Study Details

Study Description

Brief Summary

The design of the study includes 3 groups for women with premenstrual syndrome, 1low dose acupuncture in the low-dose group, 2 high dose acupuncture in the high-dose group, and 3 the drug group (contraceptives) . Serum marker change of PGE2, CA125, E2, and progesterone in enrolled patients will be measured before and after treatment, along with VAS and MDQ questionnaires. The treatment efficacy of different groups and the relationship between PMS and patients TCM syndrome pattern will also be recorded and estimated.

Condition or Disease Intervention/Treatment Phase
  • Drug: NSAIDs or oral contraceptives treatment
  • Device: Low dose acupuncture
  • Device: High dose acupuncture
N/A

Detailed Description

Premenstrual syndrome (PMS) is the sum of a group of symptoms (including physical and psychological symptoms) that occurs during the luteal phase of the menstrual cycle. Women who have such symptoms have been estimated as high as 75%; of which 3% to 8% are severe symptoms, called premenstrual dysphoric disorder (premenstrualdysphoric syndrome, PMDD). The two groups are very similar. PMS is mostly for physical discomfort, while PMDD is for emotional problems, affecting women's sleep seriously.

Regarding the treatment of premenstrual syndrome (PMS), western medicine adopt oral contraceptive pills (OCP) as the first-line medication. However, the common side effects of OCP, such as headache, dizziness, nausea, vomiting, depression, breast pain and so on are also troublesome, In recent years, some women also use acupuncture as an adjunctive replacement therapy because of its safety and fewer side effects. Nevertheless, the factors affecting treatment effect of acupuncture and moxibustion. such as the selection of acupoint s ( of which meridians) or number(dose) of acupuncture ,etc., maight affect the efficacy, yet the relevant research on this issue is not enough. In traditional Chinese medicine theory, acupuncture and moxibustion regulate the energy of the meridians and adjust blood and qi, which in turn help the balance of yin and yang. Female menstrual cycle is a process of conversion between yin and yang in TCM theory. While in western medicine, it is regulated by the endocrine system.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
105 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Effect of Different Acupuncture Dose on Premenstrual Syndrome and the Relationship Between Premenstrual Syndrome and TCM Syndrome Complex
Actual Study Start Date :
Jan 1, 2019
Anticipated Primary Completion Date :
Sep 18, 2020
Anticipated Study Completion Date :
Sep 18, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional Gynecologic Treatment group

Taking NSAIDs or oral contraceptives.NSAIDs include Ibuprofen, Naproxen, Diclofenac, and Piroxicam. Oral contraceptives include Yasmin.

Drug: NSAIDs or oral contraceptives treatment
Taking NSAIDs or oral contraceptives.NSAIDs include Ibuprofen, Naproxen, Diclofenac, and Piroxicam. Oral contraceptives include Yasmin.
Other Names:
  • Taking NSAIDs or oral contraceptives.NSAIDs include Ibuprofen, Naproxen, Diclofenac, and Piroxicam. Oral contraceptives include Yasmin.
  • Experimental: Low dose acupuncture group

    Acupuncture has fewer acupuncture points.

    Device: Low dose acupuncture
    Six acupoints: Three Yin Intersection( SP6)、Grandfather Grandson(SP4)、 Sea of Blood(SP10) 、Sea of Qi(RN6)、Origin Pass(RN4) 、Inner Pass(PC6)

    Experimental: High dose acupuncture group

    Acupuncture has more acupuncture points.

    Device: High dose acupuncture
    Twelve acupoints: Three Yin Intersection( SP6)、Grandfather Grandson(SP4)、 Sea of Blood(SP10) 、Sea of Qi(RN6)、Origin Pass(RN4) 、Middle Extremity(RN3)、Inner

    Outcome Measures

    Primary Outcome Measures

    1. Wang Qi Chinese Medicine Questionnaire [Change from Baseline TCM constitutions at 4 cycles (each cycle is 30 days).]

      This questionnaire is used to survey TCM constitutions. Evaluate body constitution of

    Secondary Outcome Measures

    1. Visual analogue scale(VAS) score [Change from Baseline VAS score at 4 cycles (each cycle is 30 days).]

      VAS is used to assess the extent of menstrual pain.

    2. Blood test estrogen [Change from Baseline blood test at 4 cycles (each cycle is 30 days).]

    3. Blood test progesterone [Change from Baseline blood test at 4 cycles (each cycle is 30 days).]

    4. Blood test prostaglandin [Change from Baseline blood test at 4 cycles (each cycle is 30 days).]

    5. Menstrual Distress Questionnaire(MDQ) [Change from Baseline Menstrual Distress Questionnaire at 4 cycles (each cycle is 30 days).]

      Contain: Pain;Concentration;Behavioral Change;Autonomic Reactions;Water Retention;Negative Affect

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 49 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1.15 to 49 years 2.with a history of regular menstrual cycles (28days±7 days) 3.Symptoms:breast pain、dizziness、bloating、cramps、nausea、vomiting、 diarrhea、headache、 fatigue,etc

    Exclusion Criteria:
    1. irregular menstrual cycles

    2. intrauterine contraceptive device (IUCD/IUD)

    3. uncontrolled neurological diseases

    4. lactation, pregnant women,or those with plans to get pregnant in the coming half year

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Taipei City H Taipei Taiwan

    Sponsors and Collaborators

    • Taipei City Hospital

    Investigators

    • Principal Investigator: Tsai-Ju Chien, Taipei City Hospital
    • Study Director: Yi-Shuo Huang, Taipei City Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Taipei City Hospital
    ClinicalTrials.gov Identifier:
    NCT04296422
    Other Study ID Numbers:
    • TCHIRB-10712111
    First Posted:
    Mar 5, 2020
    Last Update Posted:
    Mar 5, 2020
    Last Verified:
    Feb 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Taipei City Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 5, 2020